Schambye Hans T.

CIK 00018257761 companyCOPENHAGEN N G7, G7

SEC Profile

Transactions

Companies

Filings

CIK

0001825776

Recent Transactions

22 trades

Sale
Damora Therapeutics, Inc.$DMRA
Common Stock
2026-01-02$21.38/sh−700→ 4,682 total
Exercise/Conversion
Damora Therapeutics, Inc.$DMRA
Common Stock
2026-01-02+1,360→ 5,382 total
Exercise/Conversion
Damora Therapeutics, Inc.$DMRA
Restricted Stock Units
2026-01-02−1,360→ 2,640 total
Exercise/Conversion
Damora Therapeutics, Inc.$DMRA
Common Stock
2025-07-03+1,360→ 4,757 total
Exercise/Conversion
Damora Therapeutics, Inc.$DMRA
Restricted Stock Units
2025-07-03−1,360→ 4,000 total
Sale
Damora Therapeutics, Inc.$DMRA
Common Stock
2025-07-03$3.38/sh−735→ 4,022 total
Exercise/Conversion
Damora Therapeutics, Inc.$DMRA
Common Stock
2025-01-03+2,640→ 4,738 total
Award
Damora Therapeutics, Inc.$DMRA
Stock Option (right to buy)
2025-01-03+16,400→ 16,400 total
Sale
Damora Therapeutics, Inc.$DMRA
Common Stock
2025-01-03$5.60/sh−1,341→ 3,397 total
Exercise/Conversion
Damora Therapeutics, Inc.$DMRA
Restricted Stock Units
2025-01-03−2,640→ 5,360 total
Award
Damora Therapeutics, Inc.$DMRA
Stock Option (right to buy)
2024-10-09+44,100→ 44,100 total
Award
Damora Therapeutics, Inc.$DMRA
Restricted Stock Units
2024-01-03+200,000→ 200,000 total
Award
Damora Therapeutics, Inc.$DMRA
Stock Option (right to buy)
2023-01-04+300,000→ 300,000 total
Purchase
Damora Therapeutics, Inc.$DMRA
Common Stock
2022-03-22$2.15/sh+5,000→ 52,428 total
Award
Damora Therapeutics, Inc.$DMRA
Stock Option (right to buy)
2022-01-04+287,500→ 287,500 total
Purchase
Damora Therapeutics, Inc.$DMRA
Common Stock
2021-11-09$3.50/sh+4,500→ 47,428 total
Purchase
Damora Therapeutics, Inc.$DMRA
Common Stock
2021-06-24$5.11/sh+3,000→ 42,928 total
Award
Damora Therapeutics, Inc.$DMRA
Stock Option (right to buy)
2021-01-05+230,000→ 230,000 total
Conversion
Damora Therapeutics, Inc.$DMRA
Series C-1 Preferred Stock
2020-11-02−5,359→ 0 total
Conversion
Damora Therapeutics, Inc.$DMRA
Common Stock
2020-11-02+13,931→ 39,928 total
Award
Damora Therapeutics, Inc.$DMRA
Stock Option (right to buy)
2020-10-07+519,940→ 519,940 total
Award
Damora Therapeutics, Inc.$DMRA
Stock Option (right to buy)
2020-06-24+207,976→ 207,976 total

Companies

Damora Therapeutics, Inc.
Director, Chief Executive Officer
$DMRA

Recent Filings

Address

OLE MAALOES VEJ 3 C/O GALECTO, INC.

COPENHAGEN N G7, G7, DK-2200

View on SEC.gov